| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918150 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
IMRT+S is cost-effective compared to IMRT-O based on its potential to reduce radiotherapy-related toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ben G.L. Vanneste, Madelon Pijls-Johannesma, Lien Van De Voorde, Emile N. van Lin, Kees van de Beek, Judith van Loon, Bram L. Ramaekers, Philippe Lambin,